Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda ‐ Lombardy Hematologic Network, Italy)
暂无分享,去创建一个
D. Consonni | A. Santoro | R. Cairoli | A. Cortelezzi | N. Fracchiolla | A. Assanelli | M. Bernardi | E. Todisco | N. Orofino | L. Marbello | V. Mancini | F. Guidotti | S. Gandolfi | A. Bilancia
[1] Salvatore Giacomo Morano,et al. Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC) , 2015, Supportive Care in Cancer.
[2] J. Kato,et al. A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies , 2014, International Journal of Hematology.
[3] V. Chopra,et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis , 2013, The Lancet.
[4] S. Kaufmann,et al. Comparison of complication rates of Hickman® catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy , 2013, Leukemia & lymphoma.
[5] A. Clements,et al. Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study. , 2011, The Journal of hospital infection.
[6] J. Seymour,et al. Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices , 2009, Supportive Care in Cancer.
[7] Simon Heath,et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15 , 2007, Nature Genetics.